Each year, the Brain Tumor Institute at Children’s National evaluates more than 100 new patients with brain tumors, and is recognized as a world leader in childhood brain tumor care and research. Children’s National has pioneered novel pediatric brain tumor therapies, including new molecularly-targeted therapies, vaccines, T-cell immunotherapies, and less invasive techniques. They are currently ranked #6 among children’s cancer hospitals by U.S News & World Report.
Children treated at Children’s National Hospital have access to the latest, most effective treatments for brain tumors, and are care for by a multidisciplinary team of experts in both neurology and oncology, are committed to saving lives and providing the best possible care for children with brain tumors.
Principal CBTTC Investigators: Roger Packer, MD; Javad Nazarian, PhD, MSc; Brian Rood, MD
Additional CBTTC Investigators: Eugene Hwang, MD; Miriam Bornhorst, MD
